- Category eNews
- DATE 29 Jun 2022
Breast Cancer Trials
43rd Annual Scientific Meeting
The Breast Cancer Trials 43rd Annual Scientific Meeting (ASM) will be held from 27-29 July 2022 at The Langham, Melbourne, and is the premier event for breast cancer clinical trials research.
The theme of the ASM is breast cancer in young women, with a number of key presentations on this important topic.
Each year, the event attracts leading breast cancer experts from a range of disciplines. The 2022 international guest speakers are:
- Charlotte Coles – Professor of Breast Cancer Clinical Oncology and Deputy Head of the Department of Oncology, University of Cambridge
- Laura Esserman – Professor of Surgery and Radiology at the University of California, San Francisco, and Director of the UCSF Breast Cancer Clinic
- Hiroji Iwata – Vice Director and Chief of Breast Oncology, Aichi Cancer Centre Hospital, Clinical Professor at Nagoya University Medical School, Japan
- Ann Partridge – Professor of Medicine, Harvard Medical School & Vice Chair of Medical Oncology, Dana-Faber Cancer Institute
- Hope Rugo – Professor of Medicine in the Division of Hematology and Oncology at the University of California, San Francisco
The program includes two days of Scientific Sessions covering: prevention/screening/diagnosis; early breast cancer; advanced disease; and translational research. For those who are unable to attend the ASM in person, the Scientific Sessions will be available to watch online at a reduced registration rate.
The Trials Coordination Forum is a yearly day long workshop for staff at participating institutions and trial coordinators, which will provide an update on developments and changes within the Breast Cancer Trials (BCT) research program, a recap on important trial results, insights into health economics and is a valuable networking opportunity for those involved in clinical trials management.
For the first time, the ASM program includes oral presentations selected from submitted abstracts. Abstracts describing work relating to clinical trials in progress or completed, projects that may inform future clinical trials and projects identifying issues for which clinical trials may be beneficial are all welcome. Abstracts from trainees, Fellows and Junior faculty from all breast cancer disciplines are particularly welcome. Some abstracts will be offered oral presentations and others offered posters to be displayed during the ASM. Prizes will be awarded for the best abstracts. The deadline for abstract submission is 6 July 2022.
Also in a first for the ASM is a Trainee and Early Career Day for trainees in medical oncology, radiation oncology and surgical oncology, to be held on Saturday 30 July. This is a free multi-disciplinary session, with both presentations and panel discussions from leading Australian and international breast cancer experts. The day will focus on the management of early breast cancer, with updates on the latest in evidenced based research.
To find out more about BCT’s 43rd ASM or to register, visit www.bct2022.org.
Clinical Fellowship Opportunities
BCT started the Clinical Fellowship Program in 2021, with the aim of developing new research ideas and supporting the next generation of researchers.
The Program is aimed at early career researchers, who have a high-level interest in clinical research and qualifications in the disciplines of medical oncology, pathology, psychology and other supportive care specialties, radiation oncology, radiology or surgery.
Fellows work on projects that are directly relevant to BCT that potentially involve:
- Research areas of future trials including background and pilot work
- Work on existing or future BCT clinical trials
- Further analysis of data from existing trials
- Participation in trial meetings to drive the research as directed by our strategy
Applications for the 2023 Fellowship Program will open shortly. These positions will provide an exciting opportunity for an early career researcher to be funded in a part-time capacity (1-2 days per week) for a one-year term with a second-year extension possible. Applications will close 15 August and successful applicants will be notified in early September 2022. For a confidential conversation about the Fellowships, please contact the BCT Director of Research, Professor Bruce Mann, at DoR@bctrials.org.au. More information can be obtained by emailing firstname.lastname@example.org.
Dr Janice Yeh was awarded a Clinical Fellowship in 2021
Online Q&A: Breast Cancer in Young Women
Our next online Q&A event will discuss the important topic of ‘breast cancer in young women’ and will be broadcast live from Federation Square, Melbourne, from 5:30-7pm (AEST) on Wednesday 27 July 2022.
Moderated by TV presenter Annabel Crabb, the panel will include Professor Ann Partridge, Associate Professor Nicholas Wilcken, Associate Professor Lesley Stafford, Consumer Advisory Panel Chair Ms Leslie Gilham and clinical trial participant Ms Laura McCambridge. For more information or to register to watch the event online, visit www.breastcancertrials.org.au.
COSAoncology 12 hours ago
🚨 Submit your #COSA22 abstract TODAY 🚨 Need a deadline to work to? Here it is! #COSA22 abstract submissions close MIDNIGHT AEST tonight!Last chance to finalise & submit ➡️ https://t.co/Pr91BEYqHH pic.twitter.com/OLsoPloe4PRead More >
COSA members can make an impact on cancer control by subscribing to as many COSA Groups as they like! 🤝 Collaborate with COSA's multidisciplinary membership and contribute to Group activities.🖱️ Log in and update your preferences: https://t.co/WdMufywsoR pic.twitter.com/NLyeUlDJPURead More >
We're looking for a proactive people person to enhance COSA member engagement & experience.The Membership Officer role is a part-time, flexible, 12 mth contract (with potential to renew). Contact us with Qs or apply now. Pls share with your networks! https://t.co/SMnzfElU80 pic.twitter.com/NZSTa5QtJARead More >
Attention NSW and ACT researchers: expressions for the Enduring Cancer Data Linkage (CanDLe) program are now open. Details and applications: https://t.co/A1nLvVfQ0P pic.twitter.com/e6xKH2pUnnRead More >
COSAoncology 2 days ago
With >30 #cancer #nurse leaders & our member organisations, our @ISNCC team has developed an international competency framework re. self-management support for ppl with cancer. —> https://t.co/3IiDfob6p7@CNSA_ORG @oncologynursing @CanoResearch #SelfMangement #survonc #supponc pic.twitter.com/FSjiIVqldpRead More >
COSAoncology 2 days ago
📣 2 days left to submit your #COSA22 abstract.Finalise your oral & poster presentation abstracts and SUBMIT BY MIDNIGHT AEST THIS FRIDAY 12 AUGUST.We look forward to your innovative & important research.Submit at ➡️ https://t.co/Pr91BEYqHH pic.twitter.com/qIrq4ZDVOhRead More >
COSAoncology 3 days ago
Cancer Australia welcomes the launch of 8 new Optimal Care Pathways (OCPs) for blood cancer. OCPs set national standards of blood cancer treatment and care. Find out more at https://t.co/hwmKxowvst #BloodCancer @LeukaemiaAus pic.twitter.com/BSmG21ENozRead More >
COSAoncology 3 days ago
💻 Our guidelines for fertility preservation for people with #cancer are live! 👶 Designed by HPs, for HPs, these guidelines will assist in discussing & managing fertility preservation for children, adolescents & adults of reproductive age @thewomens @ANZoncofert pic.twitter.com/oRkjkISLKcRead More >
COSAoncology 3 days ago
Registrations are open for the @TOGAANZ 2022 Lung Cancer PreceptorshipAn active learning 2-day workshop 4 medical trainees & fellows to develop clinical knowledge & expertise in thoracic cancer mgmt & engage w mentors https://t.co/l8KHDxODex#LCSM pic.twitter.com/j8vmPpnOgFRead More >
COSAoncology 4 days ago
AOMA Summit 2022 videos are now available to watch on the MASC Trials YouTube Channel. Featuring international and Australian experts in ocular melanoma as well as consumers.📺 https://t.co/cxbIK7d5Ga#Ocular #Uveal #Melanoma #AOMA22 #EyeCancer@AnthonyMJoshua @DrDamienKee pic.twitter.com/MD64Q1Bx7QRead More >